Article citationsMore>>

Tanaka, K., Kezuka, T., Ishikawa, H., Tanaka, M., Sakimura, K., Abe, M., et al. (2023) Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review. International Journal of Molecular Sciences, 24, Article 13368.
https://doi.org/10.3390/ijms241713368

has been cited by the following article:

• TITLE: Progress in the Pathological Mechanism and Treatment of Optic Neuritis

  AUTHORS: Hongguang Lu, Wenhao Ma

  KEYWORDS: Optic Neuritis, Pathological Mechanism, Treatment Progress

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.12, December 23, 2024

  ABSTRACT: Optic neuritis (ON) is a kind of inflammatory disease characterized by optic nerve damage, which can lead to vision loss or even blindness. With the development of ON pathology, the medical community has gained a more comprehensive understanding of its immune-mediated complex processes. In addition, the treatment method has also developed from a single hormone therapy to a variety of treatment strategies including immunosuppressants, plasma exchange, immunoadsorption, etc., and the emerging therapy of stem cell transplantation has become the focus of attention. This review aims to explore the latest pathomechanisms of optic neuritis, comprehensively analyze the current therapeutic research advances, and provide a reference for future therapeutic directions.